University of Minnesota Launches COVID-19 Antibody Test

MINNEAPOLIS, MN- April 14, 2020 – The University of Minnesota has developed a COVID-19 antibody test that will be available first to frontline health care workers in M Health Fairview’s Bethesda hospital. 

The lab of Marc Jenkins, PhD, a Regents and Distinguished McKnight University professor at the Medical School and director of the Center for Immunology, completed the initial work to ensure the tests were fully validated. In less than three weeks, Jenkins’ team both completed the enzyme-linked immunosorbent assay, or ELISA, that allowed for detection of COVID-19 antibodies, as well as testing its accuracy. 

“We are fortunate that we have colleagues like Fang Li in the Department of Veterinary and Biomedical Sciences who quickly isolated the molecular basis of this virus and provided us with samples of the key proteins,” said Jenkins. 

Fang Li, PhD, an associate professor in the College of Veterinary Medicine, was among the first to publish a peer-reviewed article in Nature detailing the underlying structure of COVID-19. 

On March 21, Li provided protein material to the Jenkins Lab, and work began. 

By April 9, the Jenkins team turned over its test to the U of M’s Advanced Research and Diagnostic Lab led by Amy Karger, MD, where the test was repeated and further validated with additional samples. 

“What makes this test different is that it was developed here in Minnesota, meaning we aren’t relying on an outside supply chain for kit parts from another part of the world,” said Tim Schacker, MD, Vice Dean for Research at the Medical School. “And, the test has had good results with people who are ten days out from their symptoms giving positive immune response results.” 

###

About the University of Minnesota Medical School

The University of Minnesota Medical School is at the forefront of learning and discovery, transforming medical care and educating the next generation of physicians. Our graduates and faculty produce high-impact biomedical research and advance the practice of medicine. Visit med.umn.edu to learn how the University of Minnesota is innovating all aspects of medicine.

Share this post

Related News

  • Transplant Expert Becomes Transplant Minnesotan

    Andrew Adams, MD, PhD, has joined the Department of Surgery as a professor and as chief of the Division of Transplantation at both M Health Fairview University of Minnesota hospitals. He brings $11.7 million in funding from the National Institutes of Health focused on developing novel therapies to improve outcomes for transplant patients.

  • Study Analyzes if Telemedicine is Efficacious in Treating Opioid Use Disorder

    Federal and state agencies have temporarily allowed unprecedented flexibility for the use of telemedicine, including audio-only visits, for encounters where opioid use disorder (OUD) medications are prescribed. Cuong Pham, MD, an assistant professor in the Department of Medicine, is analyzing telemedicine’s efficacy for patients with OUD during COVID-19.

  • Researchers Study Cortisol Levels, Decision-Making in COVID-19 Healthcare Workers

    Alexander Herman, MD, PhD, in the Department of Psychiatry and Behavioral Sciences, and David Darrow, MD, MPH, in the Department of Neurosurgery, are studying hair samples from frontline healthcare workers during the COVID-19 pandemic to determine how their cortisol levels might correlate with their responses on a multi-armed bandit task.”